APA (7th ed.) Citation

Abdul Aziz, M. H., Lipman, J., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., . . . Roberts, J. A. (2015). Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. Oxford University Press.

Chicago Style (17th ed.) Citation

Abdul Aziz, Mohd. Hafiz, et al. Is Prolonged Infusion of Piperacillin/tazobactam and Meropenem in Critically Ill Patients Associated with Improved Pharmacokinetic/pharmacodynamic and Patient Outcomes? An Observation from the Defining Antibiotic Levels in Intensive Care Unit Patients (DALI) Cohort. Oxford University Press, 2015.

MLA (8th ed.) Citation

Abdul Aziz, Mohd. Hafiz, et al. Is Prolonged Infusion of Piperacillin/tazobactam and Meropenem in Critically Ill Patients Associated with Improved Pharmacokinetic/pharmacodynamic and Patient Outcomes? An Observation from the Defining Antibiotic Levels in Intensive Care Unit Patients (DALI) Cohort. Oxford University Press, 2015.